Vascular Disease Devices Market by Product (Stents, Balloons, Catheters, Hemodynamic Flow Alteration Devices, Plaque Modification Devices, and Inferior Vena Cava Filters), End-user (Hospitals & Cardiac Centers and Ambulatory Surgical Center), and Regional Analysis (North America, Europe, Asia-Pacific, and LAMEA): Global Opportunity Analysis and Industry Forecast, 2021–2028

Global Vascular Disease Devices Market Analysis

The global vascular disease devices market is predicted to garner $22,610.3 million in the 2021–2028 timeframe, growing from $13,308.2 million in 2020, at a healthy CAGR of 6.9%.

Market Synopsis

Strategic alliances among market players, along with growth in number of cath labs are expected to accelerate the growth of the vascular disease devices market.

However, high set-up cost associated with vascular disease devices is a growth-restricting factor for the market.

According to the regional analysis, the North America vascular disease devices market is anticipated to grow during the review period with revenue of $8,727.6 million in 2028.  

Vascular Disease Devices Overview

Vascular disease is the type of disease that affects the blood circulation of the body due to factors such as high blood pressure, cholesterol, and other infections. This disease affects the circulatory system of the body through veins, arteries, and lymph. Vascular disease devices are inserted into the veins or arteries via surgery to treat the vascular malfunction.

Impact Analysis of COVID-19 on the Global Vascular Disease Devices Market

The novel coronavirus pandemic had a devastating effect on several industries including the vascular disease devices market which experienced a negative growth during this period. Due to complete lockdown worldwide, manufacturing capacity of the vascular disease devices got affected; along with this, most of the surgeries got postponed because of strict government regulations regarding performing only critical surgeries of emergency department (ED). All such factors are expected to cause the revenue loss in global vascular disease devices industry. In addition to this, in 2020, according to the Society of Thoracic Surgeons Adult Cardiac Surgery Database, adult cardiac surgery volume reduced by 52.7% in the US. Thus, above-stated factors show that the pandemic affected the global vascular disease devices market.  

Increasing Incidence of Atherosclerosis to Surge the Market Growth

The global vascular disease devices industry is witnessing a massive growth mainly due to increasing population suffering from atherosclerosis, a type of disease that is caused due to blockage in arteries due to buildup of cholesterol, fats, and other substances on artery walls. Moreover, according to the International Journal of Epidemiology, in 2019, approximately 75% of the myocardial infarctions occur because of plaque rupture in people aged 45 years or above.

Furthermore, according to a journal published by omicsonline.org, in the US, every 1 out of 58 people has atherosclerosis and 4.6 million people have this disease. Same situation arises in Australia. This type of researche and statistics showcase the demand for vascular disease devices for the treatment of such diseases. These types of initiatives drive the global vascular disease devices market.

To know more about global vascular disease devices market drivers, get in touch with our analysts here.

High Cost of Vascular Disease Devices to Restrain the Market Growth

The high set up cost of vascular disease devices is one of the factors expected to restrain the growth of the global market during the forecast period. In addition to this, lack of awareness regarding the availability of vascular disease devices mostly in developing countries is one of the aspects that may create a negative impact on the growth of the market during the forecast period.

Growing Prevalence of Peripheral Artery Disorders in the Market to Create Massive Investment Opportunities

The global vascular disease devices market is growing at a very fast pace due to increasing population with peripheral artery disorders (PAD). PAD is the condition in which arteries are unable to flow the blood towards the limbs. Moreover, changes in unhealthy dietary habits, smoking, obesity, and changes in lifestyle are some of the factors that increase the chances of developing PAD. For example, according to the American Heart Association, in America, more than 8.5 million people are affected with peripheral artery disease (PAD) yearly. All such aspects are thereby positively affecting the market growth.

Furthermore, certain key vendors operating in vascular disease devices market are adopting certain strategies and innovations for staying upfront in the competitive environment. For instance, in June 2020, Becton, Dickinson and Company, US based medical device company, announced that they have acquired Straub Medical AG, a private company that develops medical thrombectomy and atherectomy devices for the treatment of peripheral arterial disease (PAD) and venous disease. All such types of acquisitions and factors may further lead to lucrative market opportunities for key players in the upcoming years.

To know more about global vascular disease devices market opportunities, get in touch with our analysts here.

Source: Research Dive Analysis

The stents sub-segment is predicted to have a dominating as well as fastest growing market share in the global market and register a revenue of $6,715.3 million during the forecast period. Stents are tiny little tubes placed inside the artery or veins to cure blocks caused by fats or other factors. Stents help arteries to hold the open structure and allow normal blood flow. Moreover, stents’ high accuracy level and reliability are some of the major factors driving the sub-segment growth. These factors may bolster the growth of the sub-segment during the forecast period.  

Source: Research Dive Analysis

The hospitals & cardiac centers sub-segment of the global vascular disease devices market is projected to have the fastest growth as well as a dominant share and surpass $14,244.5 million by 2028, with an increase from $8,304.3 million in 2020. This growth in the market can be attributed to the rising number of people preferring hospitals & cardiac centers for their surgeries and treatments. The rapid growth of the sub-segment is attributed to better accessibility and expertise of treating diseases in hospitals. Moreover, hospitals & cardiac centers offer advanced devices along with skilled doctors & workforce which is predicted to influence patients to get treated in hospitals & cardiac centers. All such elements may increase the demand for hospitals & cardiac centers and further surge the market growth.

Source: Research Dive Analysis

The Market for Vascular Disease Devices in North America to be the Most Dominant

The North America vascular disease devices market accounted $5,150.3 million in 2020 and is projected to register a revenue of $8,727.6 million by 2028. The extensive growth of the North America vascular disease devices market is mainly driven by high disposable incomes with existence of top leading brands such as Medtronic, Abbott Laboratories, and others augmenting the industry growth in the region. Moreover, in North America, most of the people are suffering from cardiovascular devices and peripheral artery disorder which is fueling the market growth across the region. Furthermore, in 2019, according to the International Journal of Epidemiology, in the US, approximately 610,000 people suffered from heart diseases and 735,000 people experienced heart attacks. These factors will ultimately drive the demand for the vascular disease devices market across the region.

The Market for Vascular Disease Devices in Asia-Pacific to be the Fastest Growing

The share of Asia-Pacific vascular disease devices market is anticipated to grow at a CAGR of 7.7%, by registering a revenue of $5,200.4 million by 2028. The growth shall be a result of increasing trends of unhealthy dietary habits along with obesity, smoking, and lack of physical activities. Also, growing population with peripheral artery disease will increase the demand for vascular disease devices, eventually surging the North America vascular disease devices market growth, in the upcoming years. 

Competitive Scenario in the Global Vascular Disease Devices Market

Product launches and mergers & acquisitions are common strategies followed by major market players.

Source: Research Dive Analysis

Some of the leading vascular disease devices market players are Medtronic, Abbott Laboratories, Becton, Dickinson and Company, B. Braun Melsungen Ag, Boston Scientific Corporation, Terumo Corporation, Cordis, Ivascular, Merit Medical, and Venus Medtech.

Porter’s Five Forces Analysis for the Global Vascular Disease Devices Market:

• Bargaining Power of Suppliers: The service suppliers of vascular disease devices market are high in number and are larger and more globalized. So, there will be less threat from the suppliers.
  Thus, the bargaining power of suppliers is low.  
• Bargaining Power of Buyers: Buyers demand vascular disease devices that are cost-effective and government approved. This has increased the pressure on the vascular disease devices providers to offer the best product in a cost-effective way. Thus, many suppliers are offering best yet cost–effective vascular disease devices products. This gives the buyers the option to freely choose vascular disease devices that best fit their preferences.
  Thus, the bargaining power of the buyers is high.
• Threat of New Entrants: Companies entering the vascular disease devices market are adopting various innovations such as developing vascular disease devices that are high tech.
  Thus, the threat of the new entrants is moderate.
• Threat of Substitutes: The threat of a substitute product or service in vascular disease devices is low because of the presence of highly technical vascular disease devices in the industry.
  Thus, the threat of substitutes is low.
• Competitive Rivalry in the Market: The competitive rivalry among industry leaders is rather intense, especially between the global players including Medtronic and Abbott Laboratories. These companies are launching their value-added products and services in the international market and strengthening the footprint worldwide.
  Therefore, competitive rivalry in the market is high.